Electroconvulsive Therapy: Current Clinical Standards

K. Pierce, Patricia Flynn, Marty Caudle, Keith S. Garcia
{"title":"Electroconvulsive Therapy: Current Clinical Standards","authors":"K. Pierce, Patricia Flynn, Marty Caudle, Keith S. Garcia","doi":"10.1097/01.IDT.0000316718.89905.30","DOIUrl":null,"url":null,"abstract":"symptoms have existed since the early 1900s. They were developed in response to the observation that patients who suffered from endogenous seizures demonstrated relief from psychiatric symptoms. Although most of these methods were abandoned because of high rates of morbidity and mortality, the use of electrically induced controlled seizure activity to treat psychiatric disorders continued to attract attention. Over the years, ongoing refinements in the method of administrating electroconvulsive therapy (ECT) have included: • Optimization of the dosing and localization of electrical charge; • Use of anesthesia; and • Psychiatric and medical screening of patients to assess their appropriateness for treatment and to anticipate potential adverse events. As a result, ECT has become one of the safest and most broadly effective treatments, particularly for major depressive disorder (MDD). We discuss the indications for ECT, describe its administration, outline its important side effects and issues related to screening for medical risk, and review recent advances.","PeriodicalId":90307,"journal":{"name":"Psychopharm review : timely reports in psychopharmacology and device-based therapies","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2008-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.IDT.0000316718.89905.30","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharm review : timely reports in psychopharmacology and device-based therapies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.IDT.0000316718.89905.30","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

symptoms have existed since the early 1900s. They were developed in response to the observation that patients who suffered from endogenous seizures demonstrated relief from psychiatric symptoms. Although most of these methods were abandoned because of high rates of morbidity and mortality, the use of electrically induced controlled seizure activity to treat psychiatric disorders continued to attract attention. Over the years, ongoing refinements in the method of administrating electroconvulsive therapy (ECT) have included: • Optimization of the dosing and localization of electrical charge; • Use of anesthesia; and • Psychiatric and medical screening of patients to assess their appropriateness for treatment and to anticipate potential adverse events. As a result, ECT has become one of the safest and most broadly effective treatments, particularly for major depressive disorder (MDD). We discuss the indications for ECT, describe its administration, outline its important side effects and issues related to screening for medical risk, and review recent advances.
电休克疗法:现行临床标准
症状从20世纪初就存在了。它们是根据观察到患有内源性癫痫发作的患者表现出精神症状的缓解而开发的。尽管由于发病率和死亡率高,大多数这些方法被放弃,但使用电诱导控制癫痫发作活动来治疗精神疾病继续引起人们的注意。多年来,电休克治疗(ECT)方法的不断改进包括:•优化剂量和电荷定位;•麻醉的使用;•对患者进行精神病学和医学筛查,以评估其是否适合治疗并预测潜在的不良事件。因此,ECT已成为最安全、最有效的治疗方法之一,尤其是对重度抑郁症(MDD)。我们讨论电痉挛疗法的适应症,描述其管理,概述其重要的副作用和与筛查医疗风险相关的问题,并回顾最近的进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信